Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Assets Average (2016 - 2025)

Historic Assets Average for Medifast (MED) over the last 15 years, with Q4 2025 value amounting to $258.1 million.

  • Medifast's Assets Average fell 1029.94% to $258.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $258.1 million, marking a year-over-year decrease of 1029.94%. This contributed to the annual value of $266.1 million for FY2025, which is 1042.46% down from last year.
  • According to the latest figures from Q4 2025, Medifast's Assets Average is $258.1 million, which was down 1029.94% from $268.8 million recorded in Q3 2025.
  • In the past 5 years, Medifast's Assets Average ranged from a high of $409.9 million in Q1 2022 and a low of $258.1 million during Q4 2025
  • In the last 5 years, Medifast's Assets Average had a median value of $316.9 million in 2023 and averaged $319.3 million.
  • Its Assets Average has fluctuated over the past 5 years, first skyrocketed by 5904.76% in 2021, then tumbled by 2219.45% in 2023.
  • Medifast's Assets Average (Quarter) stood at $384.8 million in 2021, then decreased by 16.52% to $321.3 million in 2022, then decreased by 1.97% to $315.0 million in 2023, then dropped by 8.65% to $287.7 million in 2024, then fell by 10.3% to $258.1 million in 2025.
  • Its Assets Average was $258.1 million in Q4 2025, compared to $268.8 million in Q3 2025 and $274.7 million in Q2 2025.